Aguiar JA, Li EV, Siddiqui MR, Soliman MA, Kumar SKSR, Schaeffer EM, Keeter MK, Brown CH, Szymaniak BM, Ross AE (2023) Utilization of genetic testing in men with advanced prostate cancer. Prostate 83(6):516–523. https://doi.org/10.1002/pros.24480
Berro T, Barrett E, AlDubayan SH (2021) Clinical multigene testing for prostate Cancer. Urol Clin North Am 48(3):297–309. https://doi.org/10.1016/j.ucl.2021.03.002
Borno HT, Odisho AY, Gunn CM, Pankowska M, Rider JR (2021) Disparities in precision medicine-Examining germline genetic counseling and testing patterns among men with prostate cancer. Urol Oncol, 39(4), 233 e239-233 e214. https://doi.org/10.1016/j.urolonc.2020.10.014
Cancer Stat Facts: Common Cancer Sites. (2022) National Cancer Institute. Retrieved December 11 from https://seer.cancer.gov/statfacts/html/common.html
Chapman-Davis E, Zhou ZN, Fields JC, Frey MK, Jordan B, Sapra KJ, Chatterjee-Paer S, Carlson AD, Holcomb KM (2021) Racial and ethnic disparities in genetic testing at a hereditary breast and ovarian Cancer center. J Gen Intern Med 36(1):35–42. https://doi.org/10.1007/s11606-020-06064-x
Childers KK, Maggard-Gibbons M, Macinko J, Childers CP (2018) National distribution of Cancer genetic testing in the united States: evidence for a gender disparity in hereditary breast and ovarian Cancer. JAMA Oncol 4(6):876–879. https://doi.org/10.1001/jamaoncol.2018.0340
Article PubMed PubMed Central Google Scholar
Chowdhury-Paulino IM, Ericsson C, Vince R Jr., Spratt DE, George DJ, Mucci LA (2022) Racial disparities in prostate cancer among black men: epidemiology and outcomes. Prostate Cancer Prostatic Dis 25(3):397–402. https://doi.org/10.1038/s41391-021-00451-z
Cohen SA, Bradbury A, Henderson V, Hoskins K, Bednar E, Arun BK (2019) Genetic counseling and testing in a community setting: quality, access, and efficiency. Am Soc Clin Oncol Educ Book 39:e34–e44. https://doi.org/10.1200/edbk_238937
DeSantis CE, Siegel RL, Sauer AG, Miller KD, Fedewa SA, Alcaraz KI, Jemal A (2016) Cancer statistics for African Americans, 2016: progress and opportunities in reducing Racial disparities. CA Cancer J Clin 66(4):290–308. https://doi.org/10.3322/caac.21340
Dickey SL, Matthews C, Millender E (2020) An exploration of precancer and Post-Cancer diagnosis and health communication among African American prostate Cancer survivors and their families. Am J Mens Health 14(3):1557988320927202. https://doi.org/10.1177/1557988320927202
Article PubMed PubMed Central Google Scholar
Ford CL, Airhihenbuwa CO (2010a) Critical race theory, race equity, and public health: toward antiracism praxis. Am J Public Health 100(Suppl 1):30–35. https://doi.org/10.2105/AJPH.2009.171058
Ford CL, Airhihenbuwa CO (2010b) The public health critical race methodology: praxis for antiracism research. Soc Sci Med 71(8):1390–1398. https://doi.org/10.1016/j.socscimed.2010.07.030
Giri VN, Hegarty SE, Hyatt C, O’Leary E, Garcia J, Knudsen KE, Kelly WK, Gomella LG (2019) Germline genetic testing for inherited prostate cancer in practice: implications for genetic testing, precision therapy, and cascade testing. Prostate 79(4):333–339. https://doi.org/10.1002/pros.23739
Article CAS PubMed Google Scholar
Giri VN, Knudsen KE, Kelly WK, Cheng HH, Cooney KA, Cookson MS, Dahut W, Weissman S, Soule HR, Petrylak DP, Dicker AP, AlDubayan SH, Toland AE, Pritchard CC, Pettaway CA, Daly MB, Mohler JL, Parsons JK, Carroll PR, Gomella LG (2020) Implementation of germline testing for prostate cancer: Philadelphia prostate Cancer consensus conference 2019. J Clin Oncol 38(24):2798–2811. https://doi.org/10.1200/JCO.20.00046
Article CAS PubMed PubMed Central Google Scholar
Greenberg S, Slager S, Neil BO, Cooney K, Maughan B, Stopa N, Venne V, Zickmund S, Colonna S (2020) What men want: qualitative analysis of what men with prostate cancer (PCa) want to learn regarding genetic referral, counseling, and testing. Prostate 80(5):441–450. https://doi.org/10.1002/pros.23959
Article PubMed PubMed Central Google Scholar
Hammond WP (2010) Psychosocial correlates of medical mistrust among African American men. Am J Community Psychol 45(1–2):87–106. https://doi.org/10.1007/s10464-009-9280-6
Article PubMed PubMed Central Google Scholar
Israel BA, Schulz AJ, Parker EA, Becker AB (1998) Review of community-based research: assessing partnership approaches to improve public health. Annu Rev Public Health 19:173–202. https://doi.org/10.1146/annurev.publhealth.19.1.173
Article CAS PubMed Google Scholar
Joseph G, Pasick RJ, Schillinger D, Luce J, Guerra C, Cheng JKY (2017) Information mismatch: Cancer risk counseling with diverse underserved patients. J Genet Couns 26(5):1090–1104. https://doi.org/10.1007/s10897-017-0089-4
Article PubMed PubMed Central Google Scholar
Kinney AY, Gammon A, Coxworth J, Simonsen SE, Arce-Laretta M (2010) Exploring attitudes, beliefs, and communication preferences of Latino community members regarding BRCA1/2 mutation testing and preventive strategies. Genet Med 12(2):105–115. https://doi.org/10.1097/GIM.0b013e3181c9af2d
Article PubMed PubMed Central Google Scholar
Kwon DH, Borno HT, Cheng HH, Zhou AY, Small EJ (2020) Ethnic disparities among men with prostate cancer undergoing germline testing. Urol Oncol, 38(3), 80 e81-80 e87. https://doi.org/10.1016/j.urolonc.2019.09.010
Loeb S, Li R, Nolasco S, Byrne T, Cheng N, Becker HH, Leader D, A. E., Giri VN (2021) Barriers and facilitators of germline genetic evaluation for prostate cancer. Prostate 81(11):754–764. https://doi.org/10.1002/pros.24172
Lumpkins CY, Philp A, Nelson KL, Miller LM, Greiner KA (2020) A road map for the future: an exploration of attitudes, perceptions, and beliefs among African Americans to tailor health promotion of cancer-related genetic counseling and testing. J Genet Couns 29(4):518–529. https://doi.org/10.1002/jgc4.1277
MacFarlane IM, Veach PM, LeRoy B (2014) Genetic counseling research: A practical guide. Genetic Counseling in Practice
Mateo J, Carreira S, Sandhu S, Miranda S, Mossop H, Perez-Lopez R, Nava Rodrigues D, Robinson D, Omlin A, Tunariu N, Boysen G, Porta N, Flohr P, Gillman A, Figueiredo I, Paulding C, Seed G, Jain S, Ralph C, de Bono JS (2015) DNA-Repair defects and Olaparib in metastatic prostate Cancer. N Engl J Med 373(18):1697–1708. https://doi.org/10.1056/NEJMoa1506859
Article CAS PubMed PubMed Central Google Scholar
McLeroy KR, Bibeau D, Steckler A, Glanz K (1988) An ecological perspective on health promotion programs. Health Educ Q 15(4):351–377. https://doi.org/10.1177/109019818801500401
Article CAS PubMed Google Scholar
National Comprehensive Cancer Network (2022a) Prostate Cancer (Version 1.2023). Retrieved December 11 from https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf
National Comprehensive Cancer Network (2022b) Prostate Cancer Early Detection (Version 1.2022). Retrieved December 11 from https://www.nccn.org/professionals/physician_gls/pdf/prostate_detection.pdf
Nettey OS, Walker AJ, Keeter MK, Singal A, Nugooru A, Martin IK, Ruden M, Gogana P, Dixon MA, Osuma T, Hollowell CMP, Sharifi R, Sekosan M, Yang X, Catalona WJ, Kajdacsy-Balla A, Macias V, Kittles RA, Murphy AB (2018) Self-reported black race predicts significant prostate cancer independent of clinical setting and clinical and socioeconomic risk factors. Urol Oncol 36(11):501 e501-501 e508. https://doi.org/10.1016/j.urolonc.2018.06.011
Article PubMed Central Google Scholar
Padamsee TJ, Meadows R, Hils M (2021) Layers of information: interacting constraints on breast cancer risk-management by high-risk African American women. Ethn Health 26(6):787–810. https://doi.org/10.1080/13557858.2018.1562053
Peterson JM, Pepin A, Thomas R, Biagi T, Stark E, Sparks AD, Johnson K, Kaltman R (2020) Racial disparities in breast cancer hereditary risk assessment referrals. J Genet Couns 29(4):587–593. https://doi.org/10.1002/jgc4.1250
Poulson MR, Helrich SA, Kenzik KM, Dechert TA, Sachs TE, Katz MH (2021) The impact of Racial residential segregation on prostate cancer diagnosis and treatment. BJU Int 127(6):636–644. https://doi.org/10.1111/bju.15293
Press DJ, Shariff-Marco S, Lichtensztajn DY, Lauderdale D, Murphy AB, Inamdar PP, DeRouen MC, Hamilton AS, Yang J, Lin K, Hedeker D, Haiman CA, Cheng I, Gomez SL (2022) Contributions of social factors to disparities in prostate Cancer risk profiles among black men and Non-Hispanic white men with prostate Cancer in California. Cancer Epidemiol Biomarkers Prev 31(2):404–412. https://doi.org/10.1158/1055-9965.Epi-21-0697
Pritchard CC, Mateo J, Walsh MF, De Sarkar N, Abida W, Beltran H, Garofalo A, Gulati R, Carreira S, Eeles R, Elemento O, Rubin MA, Robinson D, Lonigro R, Hussain M, Chinnaiyan A, Vinson J, Filipenko J, Garraway L, Nelson PS (2016) Inherited DNA-Repair gene mutations in men with metastatic prostate Cancer. N Engl J Med 375(5):443–453. https://doi.org/10.1056/NEJMoa1603144
Comments (0)